First Line Immunotherapy for Advanced Non Small Cell Lung Cancer NSCLC [720p]
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami, FL) Clinical Associate Professor of Medicine, Herbert Wertheim Coll...
Author: cancergrace
Added: 03/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Checkpoint inhibitors for lung cancer: combating resistance
Immunotherapy has the potential to provide long-term benefits to certain lung cancer patients; however, certain patients may not respond, while others who initially respond may develop resistance. In ...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
The importance of supporting carers of lung cancer patients: an unmet need
Informal carers play an essential role in the care of many lung cancer patients. Here, Morag Farquhar, PhD, of the University of East Anglia, Norwich, UK, discusses the importance of supporting these ...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Breathlessness in lung cancer: increasing awareness
Breathlessness is a frightening and disabling symptom of lung cancer; therefore, it is vital that patients, carers, family and healthcare professionals are aware of and have strategies to tackle it. H...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Educational intervention for carers of lung cancer patients: learning about breathlessness
Breathlessness is a scary symptom for lung cancer patients and their family, who often act as informal carers. Speaking from the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in ...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
CAR T-cell therapy for lung cancer?
CAR T-cells are an exciting therapeutic area, which although promising are still in the early stages of development for solid malignancies. Speaking from the British Thoracic Oncology Group (BTOG) Ann...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer immuno-oncology clinical trial combinations: inhibiting IDO
There are numerous ongoing and planned clinical trials investigating immuno-oncology (IO) agents for lung cancer, particularly in combination with other classes of therapy moving forwards. Here, Alast...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Rapid access to lung cancer care in the UK: the NOLCP
For lung cancer, early diagnosis and staging is crucial to survival. However, the length of the lung cancer pathway differs between regions in the UK due to a variety of reasons. As explained here by ...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
The future of lung cancer management: an unmet need in the immuno-oncology era
In the coming era of lung cancer management, where the use of both targeted agents and new immunotherapies seems extremely promising, what challenges will remain? Speaking from the British Thoracic On...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
ctDNA signatures to detect lung cancer
This is an exciting time for research into the early diagnosis of lung cancer, with a number of promising options on the horizon. Here, Robert Rintoul, PhD, FRCP, of the Cancer Research UK Cambridge I...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Exhaled breath signatures for lung cancer detection: the LuCID study
There is a growing need to improve the early diagnosis of lung cancer; non-invasive, quick and accessible assays would greatly aid in this. In this interesting interview, Robert Rintoul, PhD, FRCP, of...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Identifying non-invasive biomarker assays for lung cancer: what is an appropriate control group?
A non-invasive biomarker assay to detect lung cancer would be ideal; avoiding needless biopsies and providing another step of diagnostic validation. However, finding the optimal control group to ident...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer screening challenge: how do we prevent unnecessary biopsies?
One issue with lung cancer screening is that nodules, which may or may not be malignant, can be detected, leading to unnecessary biopsies and stress for patients who do not have lung cancer. In this i...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Future challenges in lung cancer: long-term control and trial selectivity
With rapid advancements in the management of lung cancer, new questions and challenges undoubtedly arise. Here, James Spicer, PhD, FRCP, of Guy's and St Thomas' NHS Foundation Trust, London, UK, discu...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer immunotherapy: the need for predictive biomarkers
As explained here by James Spicer, PhD, FRCP, of Guy's and St Thomas' NHS Foundation Trust, London, UK, the field of lung cancer research is currently dominated by immunotherapy. Prof. Spicer highligh...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
